VEGF-A, PDGF-BB and HB-EGF engineered for promiscuous super affinity to the extracellular matrix improve wound healing in a model of type 1 diabetes
M. J. V. WHITE, P. Briquez, D. A. V. White, J. Hubbell
This paper shows that engineered growth factors with enhanced ECM binding improve wound healing in a type 1 diabetes model, with triple therapy being most effective.
bioRxiv · Jun 21, 2021Bioengineering